BackCellebrite DI Ltd - Units (1 Ord Share Class A & 1/3 War) Overview

Cellebrite DI Ltd - Units (1 Ord Share Class A & 1/3 War) Total Liabilities

Cellebrite DI Ltd - Units (1 Ord Share Class A & 1/3 War)'s total liabilities is $76M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$76.00M

Peer average

Loading

Cellebrite DI Ltd - Units (1 Ord Share Class A & 1/3 War) Total Liabilities History

Loading

Cellebrite DI Ltd - Units (1 Ord Share Class A & 1/3 War) vs. peers: Total Liabilities Comparison

Loading

Cellebrite DI Ltd - Units (1 Ord Share Class A & 1/3 War) Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cellebrite DI Ltd - Units (1 Ord Share Class A & 1/3 War) (TWCTU) FAQ

Cellebrite DI Ltd - Units (1 Ord Share Class A & 1/3 War) posts a total liabilities of $76M as of June 2021. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

Total Liabilities is one piece of Cellebrite DI Ltd - Units (1 Ord Share Class A & 1/3 War)'s financial statement story. At $76M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for TWCTU's total liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Cellebrite DI Ltd - Units (1 Ord Share Class A & 1/3 War)'s other metric pages and overview cover the third.

Judging Cellebrite DI Ltd - Units (1 Ord Share Class A & 1/3 War) against Technology peers is usually better than using a market-wide rule of thumb. Business models inside Technology are more comparable, which makes gaps in total liabilities easier to interpret. Start with $76M here, then scan peer and history charts to see if the gap is persistent.